PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Cardio-cerebrovascular Disease, Zhejiang Chinese Medical University, Hangzhou, 310053, China.\', \'Department of Chemistry, Zhejiang University, Hangzhou, 310027, China.\', \'College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, 310053, China.\', \'Integrated TCM & Western Medicine Department, Xixi Hospital of Hangzhou, Hangzhou, 310023, China.\', \'School of Basic Medical Sciences and Public Health, Zhejiang Chinese Medical University, Hangzhou, 310053, China. yjhong@zcmu.edu.cn.\', \'Integrated TCM & Western Medicine Department, Xixi Hospital of Hangzhou, Hangzhou, 310023, China. guojianchun1961@126.com.\', \'Institute of Cardio-cerebrovascular Disease, Zhejiang Chinese Medical University, Hangzhou, 310053, China. haitongw@163.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s11684-020-0825-2
?:doi
?:hasPublicationType
?:journal
  • Frontiers of medicine
is ?:pmid of
?:pmid
?:pmid
  • 33909258
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.913
?:rankingScore_hIndex
  • 25
?:title
  • Comparison of the clinical features and therapeutics of COVID-19 in cardio-cerebrovascular disease (CCVD) and non-CCVD patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33909258>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33909258>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all